Cargando…
Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20-treated patients with multiple sclerosis after three or four COVID-19 vaccinations
OBJECTIVE: To analyze anti-SARS-CoV-2-S1-IgG levels, avidity, Omicron BA.2 variant neutralizing capacity, and SARS-CoV-2-specific T cells in anti-CD20-treated patients with multiple sclerosis (aCD20pwMS) after two, three, or four COVID-19 vaccinations. RESULTS: Frequencies of aCD20pwMS with detectab...
Autores principales: | Otto, Carolin, Schwarz, Tatjana, Jeworowski, Lara M, Schmidt, Marie L, Walper, Felix, Pache, Florence, Schindler, Patrick, Niederschweiberer, Moritz, Krumbholz, Andi, Rose, Ruben, Drosten, Christian, Ruprecht, Klemens, Corman, Victor M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051002/ https://www.ncbi.nlm.nih.gov/pubmed/36974938 http://dx.doi.org/10.1177/13524585231161253 |
Ejemplares similares
-
Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis
por: Schwarz, Tatjana, et al.
Publicado: (2022) -
Oculomotor Nerve Palsy as a Presenting Symptom of Epstein-Barr Virus-Associated Infectious Mononucleosis: Case Report and Review of the Literature
por: Steiner, Leon Amadeus, et al.
Publicado: (2021) -
Impaired B Cell Recall Memory and Reduced Antibody Avidity but Robust T Cell Response in CVID Patients After COVID-19 Vaccination
por: Steiner, Sophie, et al.
Publicado: (2023) -
Humoral immune response after different SARS-CoV-2 vaccination regimens
por: Rose, Ruben, et al.
Publicado: (2022) -
Enzymatic Bioremediation of Organophosphate Compounds—Progress and Remaining Challenges
por: Thakur, Meghna, et al.
Publicado: (2019)